Circulating tumor DNA dynamics on front-line chemotherapy with bevacizumab or cetuximab in metastatic colorectal cancer: A biomarker analysis for acquired genomic alterations in CALGB/SWOG 80405 (Alliance) randomized trial.

Authors

Kanwal Raghav

Kanwal Pratap Singh Raghav

University of Texas MD Anderson Cancer Center, Houston, TX

Kanwal Pratap Singh Raghav , Fang-Shu Ou , Alan P. Venook , Federico Innocenti , Ryan Sun , Heinz-Josef Lenz , Scott Kopetz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

DOI

10.1200/JCO.2022.40.4_suppl.193

Abstract #

193

Poster Bd #

K2

Abstract Disclosures